(Información remitida por la empresa firmante)
VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More
Contact:Uschi MayerExternal Communications & PRCROMA-PHARMA GmbHCromazeile 2, A-2100 Leobendorf, AustriaM.: +43 676 84 68 68 966E: uschi.mayer@croma.at
Logo: https://mma.prnewswire.com/media/2044449...
View original content:https://www.prnewswire.co.uk/news-releases/croma-pharma-further-strengthening-its-portfolio-with-philart-biostimulators-301786087.html
Andalucía
Aragón
Cantabria
Castilla-La Mancha
Castilla y León
Catalunya
Extremadura
Galicia
Islas Canarias
Islas Baleares
Madrid
País Vasco
La Rioja
C. Valenciana
Navarra
Asturias
Murcia
Ceuta y Melilla
